University of Texas — Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

University of Texas at MD Anderson Cancer Center

Principal Investigator: Konstantin Sokolov, Ph.D., Sunil Krishnan, M.D., and Rebecca Richards-Kortum, Ph.D.

Training Focus and Objectives

Currently, there is a growing gap between new discoveries coming from academic labs and their translation into clinic. To address this problem, we have designed a training program to educate future leaders in the field of nanotechnology with specific interests in cancer translational research. Our program is based on collaboration between The University of Texas MD Anderson Cancer Center and Rice University and it combines multidisciplinary mentorship of translational research projects with hands-on coursework and seminar experiences. The program provides predoctoral and post-doctoral training. All trainees will work with at least two program faculty mentors (one from Rice and one from MD Anderson) to carry out an independent research project. In addition, fellows will write a research fellowship grant as an essential part of their preparation for independent careers. Didactic coursework will help T32 fellows to develop the skills needed to define and lead research projects that address barriers to translation of cancer nanotechnology. Incoming trainees will participate in a unique boot camp in "Cancer Management and Nanotechnology" that provides an overview of current opportunities and barriers in the field. Trainees will be introduced to federal resources in cancer nanotechnology by taking a trip to the NCI Nanotechnology Characterization Lab. Finally, trainees will gain lab management skills in an introductory course in laboratory and project management. At completion of the program, fellows will have a deep understanding of translational research in cancer nanotechnology with the demonstrated ability to carry out independent research in this multidisciplinary field.

Visit the MD Anderson CNTC website.

  • Posted: August 8, 2017

Most text on the National Cancer Institute website may be reproduced or reused freely. The National Cancer Institute should be credited as the source. Please note that blog posts that are written by individuals from outside the government may be owned by the writer, and graphics may be owned by their creator. In such cases, it is necessary to contact the writer, artist, or publisher to obtain permission for reuse.

We welcome your comments on this post. All comments must follow our comment policy.